New York, Feb. 08, 2023 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Pharmaceutical API Manufacturing Global Market Report 2023" - https ...
MISSISSAUGA, Ontario — Eurofins CDMO Alphora Inc. is excited to announce an expansion of its API capacity and capabilities with the completion of its new API manufacturing facility at its site in ...
MONTREAL and BOZEMAN, Mont., Jan. 12, 2021 /CNW/ - 5N Plus Inc. ("5N Plus"), a leading global producer of specialty chemicals and engineered materials, and Microbion Corporation ("Microbion"), a ...
MilliporeSigma and Simtra Launch Five-Year Agreement for Drug Substance, Drug Manufacturing Services
The agreement has been designed to offer a turnkey service to companies seeking faster time to market. Simtra BioPharma Solutions, a sterile injectables contract development and manufacturing ...
As per DelveInsight estimates, North America is anticipated to dominate the global biologics drug substance manufacturing market during the forecast period. In the biologics type segment of the ...
EAST RUTHERFORD, N.J., Oct. 22, 2025 /CNW/ -- Cambrex, a leading global contract development and manufacturing organization (CDMO), today announced a $120 million investment to expand its U.S.
Proven leaders in biologics manufacturing are aligning their strengths to deliver a more efficient and cost-optimized drug development supply chain, worldwide Alliance aims to expedite time to market ...
Simtra BioPharma Solutions, a CDMO, formed a five-year strategic alliance with the life science business of Germany-based Merck KGaA, which operates as MilliporeSigma in the U.S. and Canada. The ...
Throughout 2025, drugmakers of all stripes have collectively poured billions of dollars into U.S. manufacturing investments. Many of those projects have centered on later stages of the production ...
Eli Lilly has revealed the location of the first of four large-scale manufacturing facilities that it plans to build in the U.S. The company has selected Goochland County, Virginia, as the site of a ...
TAIPEI, Sept. 15, 2025 /PRNewswire/ -- Mycenax Biotech Inc. (TWO:4726), a leading biologics CDMO based in Taiwan, today announced strategic alliance with SPERA PHARMA Inc., a Japan-based expert in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback